However, an overall trend towards improved survival in patients with advanced/metastatic ASPS after introducing TKIs and ICIs supports continuing efforts to develop novel therapeutic options.
1
—
—
However, an overall trend towards improved survival in patients with advanced/metastatic ASPS after introducing TKIs and ICIs supports continuing efforts to develop novel therapeutic options.